Carlsmed (FRA:I82) Net Current Asset Value: €2.82 (As of Mar. 2026) — 18% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:I82 Carlsmed Inc FRA:I82
20 GF Score
Price €9.25
! 1 Warning Sign
View Full Analysis

What is Carlsmed Net Current Asset Value?

Carlsmed FRA:I82 -11.06% 20 Net Current Asset Value is €2.82 as of Mar. 2026, which is 100% below its 10-year median of 3.45. GuruFocus rates FRA:I82 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review. Among 272 Healthcare Providers & Services companies, Carlsmed ranks better than 68.38% on this metric.

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Carlsmed's net current asset value per share for the quarter that ended in Mar. 2026 was €2.82.

The historical rank and industry rank for Carlsmed's Net Current Asset Value or its related term are showing as below:

FRA:I82' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 2.78   Med: 3.45   Max: 3.46
Current: 3.4

During the past 3 years, the highest Price-to-Net-Current-Asset-Value Ratio of Carlsmed was 3.46. The lowest was 2.78. And the median was 3.45.

FRA:I82's Price-to-Net-Current-Asset-Value is ranked better than
68.38% of 272 companies
in the Healthcare Providers & Services industry
Industry Median: 6.02 vs FRA:I82: 3.40

Carlsmed  (FRA:I82) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Carlsmed Net Current Asset Value Related Terms


Carlsmed Net Current Asset Value Historical Data

* Premium members only.

The historical data trend for Carlsmed's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carlsmed Net Current Asset Value Chart

Carlsmed Annual Data
Trend Dec23 Dec24 Dec25
Net Current Asset Value
-1.67 -2.63 3.06

Carlsmed Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.80 -2.95 3.30 3.06 2.82

FRA:I82 vs SLP, TBRG, SPOK: Net Current Asset Value Comparison

For the Health Information Services subindustry, Carlsmed's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carlsmed Price-to-Net-Current-Asset-Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Carlsmed's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Carlsmed's Price-to-Net-Current-Asset-Value falls into.


FRA:I82
20GF Score
Carlsmed Inc FRA:I82
Net Current Asset Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carlsmed Net Current Asset Value Calculation

Carlsmed's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2025 is calculated as

Net Current Asset Value Per Share(A: Dec. 2025 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(108.179-26.688-0-0)/26.664
=3.06

Carlsmed's Net Current Asset Value (NCAV) per share for the quarter that ended in Mar. 2026 is calculated as

Net Current Asset Value Per Share(Q: Mar. 2026 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(99.826-22.941-0-0)/27.232
=2.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Current Asset Value of €2.82 mean?
Carlsmed (FRA:I82) has a Net Current Asset Value of €2.82 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Carlsmed and its competitors. This is 18% below median its historical median of 3.45. Over the past decade, Carlsmed's Net Current Asset Value has ranged from 2.78 to 3.46. According to the industry distribution chart, Carlsmed ranks #86 out of 272 companies in the Healthcare Providers & Services industry, placing it in the top 31.6%.
Is Carlsmed's Net Current Asset Value too high?
Carlsmed's current Net Current Asset Value of €2.82 is 18% below median its 10-year median of 3.45. Over the past 10 years, this metric has ranged from a low of 2.78 to a high of 3.46. Based on the distribution chart, Carlsmed ranks #86 out of 272 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Carlsmed has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Carlsmed's Net Current Asset Value compare to SLP and TBRG?
According to the Healthcare Providers & Services industry distribution chart, Carlsmed ranks #86 out of 272 companies for Net Current Asset Value. This puts Carlsmed in the upper half of its industry. The industry median Net Current Asset Value is 6.02. Historically, Carlsmed's own Net Current Asset Value has ranged from 2.78 to 3.46 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Healthcare Providers & Services company?
The median Net Current Asset Value among Healthcare Providers & Services companies is 6.02, based on 272 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Carlsmed and its competitors. For the Healthcare Providers & Services industry, the median Net Current Asset Value is 6.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carlsmed's current Net Current Asset Value is €2.82, which is 18% below median its own 10-year median of 3.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carlsmed stock overvalued right now?
Carlsmed (FRA:I82) has a current Net Current Asset Value of €2.82. The current Net Current Asset Value is €2.82, which is 18% below median its 10-year median of 3.45. Carlsmed's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Carlsmed (FRA:I82), the current Net Current Asset Value is €2.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Carlsmed Business Description

Other Exchanges CARL:USA
Address 1800 Aston Avenue, Suite 100, Carlsbad, CA, USA, 92008
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.
20GF Score

Get the complete analysis for FRA:I82

Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.25
Price